2,3,7,8-Tetrachlorodibenzodioxin Explained

See also: Dioxins and dioxin-like compounds.

2,3,7,8-Tetrachlorodibenzo-p-dioxin (TCDD) is a polychlorinated dibenzo-p-dioxin (sometimes shortened, though inaccurately, to simply 'dioxin')[1] with the chemical formula CHClO. Pure TCDD is a colorless solid with no distinguishable odor at room temperature. It is usually formed as an unwanted product in burning processes of organic materials or as a side product in organic synthesis.

TCDD is the most potent compound (congener) of its series (polychlorinated dibenzodioxins, known as PCDDs or simply dioxins) and became known as a contaminant in Agent Orange, an herbicide used in the Vietnam War.[2] TCDD was released into the environment in the Seveso disaster.[3] It is a persistent organic pollutant.

Biological activity in humans and animals

TCDD and dioxin-like compounds act via a specific receptor present in all cells: the aryl hydrocarbon (AH) receptor.[4] [5] [6] This receptor is a transcription factor which is involved in the expression of genes; it has been shown that high doses of TCDD either increase or decrease the expression of several hundred genes in rats.[7] Genes of enzymes activating the breakdown of foreign and often toxic compounds are classic examples of such genes (enzyme induction). TCDD increases the enzymes breaking down, e.g., carcinogenic polycyclic hydrocarbons such as benzo(a)pyrene.[8]

These polycyclic hydrocarbons also activate the AH receptor, but less than TCDD and only temporarily.[8] Even many natural compounds present in vegetables cause some activation of the AH receptor.[9] [10] This phenomenon can be viewed as adaptive and beneficial, because it protects the organism from toxic and carcinogenic substances. Excessive and persistent stimulation of AH receptor, however, leads to a multitude of adverse effects.[8]

The physiological function of the AH receptor has been the subject of continuous research.[11] One obvious function is to increase the activity of enzymes breaking down foreign chemicals or normal chemicals of the body as needed. There seem to be many other functions, however, related to the development of various organs and the immune systems or other regulatory functions.[11] The AH receptor is phylogenetically highly conserved, with a history of at least 600 million years, and is found in all vertebrates. Its ancient analogs are important regulatory proteins even in more primitive species.[6] In fact, knock-out animals with no AH receptor are prone to illness and developmental problems.[6] Taken together, this implies the necessity of a basal degree of AH receptor activation to achieve normal physiological function.

Toxicity in humans

In 2000, the Expert Group of the World Health Organization considered developmental toxicity as the most pertinent risk of dioxins to human beings.[12] Because people are usually exposed simultaneously to several dioxin-like chemicals, a more detailed account is given at dioxins and dioxin-like compounds.

Developmental effects

In Vietnam and the United States, teratogenic or birth defects were observed in children of people who were exposed to Agent Orange or 2,4,5-T that contained TCDD as an impurity out of the production process. However, there has been some uncertainty on the causal link between Agent Orange/dioxin exposure. In 2006, a meta-analysis indicated large amount of heterogeneity between studies and emphasized a lack of consensus on the issue.[13] Stillbirths, cleft palate, and neural tube defects, with spina bifida were the most statistically significant defects. Later some tooth defects and borderline neurodevelopmental effects have been reported.[1] After the Seveso accident, tooth development defects, changed sex ratio and decreased sperm quality have been noted.[1] Various developmental effects have been clearly shown after high mixed exposures to dioxins and dioxin-like compounds, the most dramatic in Yusho and Yu-chen catastrophes, in Japan and Taiwan, respectively.[1]

Cancer

It is largely agreed that TCDD is not directly mutagenic or genotoxic.[14] Its main action is cancer promotion; it promotes the carcinogenicity initiated by other compounds. Very high doses may, in addition, cause cancer indirectly; one of the proposed mechanisms is oxidative stress and the subsequent oxygen damage to DNA.[15] There are other explanations such as endocrine disruption or altered signal transduction.[14] [16] The endocrine disrupting activities seem to be dependent on life stage, being anti-estrogenic when estrogen is present (or in high concentration) in the body, and estrogenic in the absence of estrogen.[17]

TCDD was classified by the International Agency for Research on Cancer (IARC) as a carcinogen for humans (group 1).[18] [19] In the occupational cohort studies available for the classification, the risk was weak and borderline detectable, even at very high exposures.[20] [1] Therefore, the classification was, in essence, based on animal experiments and mechanistic considerations.[18] This was criticized as a deviation from IARC's 1997 classification rules.[21] The main problem with IARC classification is that it only assesses qualitative hazard, i.e. carcinogenicity at any dose, and not the quantitative risk at different doses.[1] According to a 2006 Molecular Nutrition & Food Research article, there were debates on whether TCDD was carcinogenic only at high doses which also cause toxic damage of tissues.[14] [15] [22] A 2011 review concluded that, after 1997, further studies did not support an association between TCDD exposure and cancer risk.[23] One of the problems is that in all occupational studies the subjects have been exposed to a large number of chemicals, not only TCDD. By 2011, it was reported that studies that include the update of Vietnam veteran studies from Operation Ranch Hand, had concluded that after 30 years the results did not provide evidence of disease.[24] On the other hand, the latest studies on Seveso population support TCDD carcinogenicity at high doses.[17] [25]

In 2004, an article in the International Journal of Cancer provided some direct epidemiological evidence that TCDD or other dioxins are not causing soft-tissue sarcoma at low doses, although this cancer has been considered typical for dioxins. There was in fact a trend of cancer to decrease.[26] This is called a J-shape dose-response, low doses decrease the risk, and only higher doses increase the risk, according to a 2005 article in the journal Dose-Response.[27]

Safety recommendations

The Joint FAO/WHO Expert Committee on Food Additives (JECFA) derived in 2001 a provisional tolerable monthly intake (PTMI) of 70 pg TEQ/kg body weight.[28] The United States Environmental Protection Agency (EPA) established an oral reference dose (RfD) of 0.7 pg/kg b.w. per day for TCDD[29] (see discussion on the differences in[1]).According to the Aspen Institute, in 2011:

The general environmental limit in most countries is 1,000 ppt TEq in soils and 100 ppt in sediment. Most industrialized countries have dioxin concentrations in soils of less than 12 ppt. The U.S. Agency for Toxic Substance and Disease Registry has determined that levels higher than 1,000 ppt TEq in soil require intervention, including research, surveillance, health studies, community and physician education, and exposure investigation. The EPA is considering reducing these limits to 72 ppt TEq. This change would significantly increase the potential volume of contaminated soil requiring treatment.[30] [31]

Animal toxicology

By far most information on toxicity of dioxin-like chemicals is based on animal studies utilizing TCDD.[2] [6] [32] [33] Almost all organs are affected by high doses of TCDD. In short-term toxicity studies in animals, the typical effects are anorexia and wasting, and even after a huge dose animals die only 1 to 6 weeks after the TCDD administration.[33] Seemingly similar species have varying sensitivities to acute effects: lethal dose for a guinea pig is about 1 μg/kg, but to a hamster it is more than 1,000 μg/kg. A similar difference can be seen even between two different rat strains.[33] Various hyperplastic (overgrowth) or atrophic (wasting away) responses are seen in different organs, thymus atrophy is very typical in several animal species. TCDD also affects the balance of several hormones. In some species, but not in all, severe liver toxicity is seen.[6] [33] Taking into account the low doses of dioxins in the present human population, only two types of toxic effects have been considered to cause a relevant risk to humans: developmental effects and cancer.[1] [6]

Developmental effects

Developmental effects occur at very low doses in animals. They include frank teratogenicity such as cleft palate and hydronephrosis.[34] Development of some organs may be even more sensitive: very low doses perturb the development of sexual organs in rodents,[34] [35] [36] and the development of teeth in rats.[37] The latter is important in that tooth deformities were also seen after the Seveso accident[38] and possibly after a long breast-feeding of babies in the 1970s and 1980s when the dioxin concentrations in Europe were about ten times higher than at present.[39]

Cancer

Cancers can be induced in animals at many sites. At sufficiently high doses, TCDD has caused cancer in all animals tested. The most sensitive is liver cancer in female rats, and this has long been a basis for risk assessment.[40] Dose-response of TCDD in causing cancer does not seem to be linear,[22] and there is a threshold below which it seems to cause no cancer. TCDD is not mutagenic or genotoxic, in other words, it is not able to initiate cancer, and the cancer risk is based on promotion[14] of cancer initiated by other compounds or on indirect effects such as disturbing defense mechanisms of the body e.g. by preventing apoptosis or programmed death of altered cells.[41] [5] Carcinogenicity is associated with tissue damage, and it is often viewed now as secondary to tissue damage.[14]

TCDD may in some conditions potentiate the carcinogenic effects of other compounds. An example is benzo(a)pyrene that is metabolized in two steps, oxidation and conjugation. Oxidation produces epoxide carcinogens that are rapidly detoxified by conjugation, but some molecules may escape to the nucleus of the cell and bind to DNA causing a mutation, resulting in cancer initiation. When TCDD increases the activity of oxidative enzymes more than conjugation enzymes, the epoxide intermediates may increase, increasing the possibility of cancer initiation. Thus, a beneficial activation of detoxifying enzymes may lead to deleterious side effects.[42]

Sources

TCDD has never been produced commercially except as a pure chemical for scientific research. It is, however, formed as a synthesis side product when producing certain chlorophenols or chlorophenoxy acid herbicides.[43] It may also be formed along with other polychlorinated dibenzodioxins and dibenzofuranes in any burning of hydrocarbons where chlorine is present, especially if certain metal catalysts such as copper are also present.[44] Usually a mixture of dioxin-like compounds is produced,[1] therefore a more thorough treatise is under dioxins and dioxin-like compounds.

The greatest production occurs from waste incineration, metal production, and fossil-fuel and wood combustion.[45] Dioxin production can usually be reduced by increasing the combustion temperature. Total U.S. emissions of PCCD/Fs were reduced from ca. 14 kg TEq in 1987 to 1.4 kg TEq in 2000.[46]

Cases of exposure

There have been numerous incidents where people have been exposed to high doses of TCDD.

See also

External links

Notes and References

  1. Tuomisto, Jouko (2019) Dioxins and dioxin-like compounds: toxicity in humans and animals, sources, and behaviour in the environment. WikiJournal of Medicine 6(1): 8 | https://doi.org/10.15347/wjm/2019.008
  2. Schecter A, Birnbaum L, Ryan JJ, Constable JD . Dioxins: an overview . Environ. Res. . 101 . 3 . 419–28 . 2006 . 16445906 . 10.1016/j.envres.2005.12.003. 2006ER....101..419S .
  3. 10.1080/026520300283379. M.H. Sweeney . P. Mocarelli . Human health effects after exposure to 2,3,7,8- TCDD. Food Addit. Contam. . 17. 4. 2000. 303–316. 10912244. 11814994 .
  4. 10.1080/026520300283333. L. Poellinger . Mechanistic aspects—the dioxin (aryl hydrocarbon) receptor.. Food Additives and Contaminants . 17. 4. 2000. 261–6. 10912240. 22295283 .
  5. Mandal PK . Dioxin: a review of its environmental effects and its aryl hydrocarbon receptor biology . J. Comp. Physiol. B . 175 . 4 . 221–30 . May 2005 . 15900503 . 10.1007/s00360-005-0483-3 . 20508397 .
  6. 10.1016/j.yfrne.2010.07.002. J. Lindén . S. Lensu . J. Tuomisto . R. Pohjanvirta. . Dioxins, the aryl hydrocarbon receptor and the central regulation of energy balance. A review. . Frontiers in Neuroendocrinology . 31. 4. 2010. 452–478. 20624415. 34036181 .
  7. Tijet N, Boutros PC, Moffat ID . 1913812. Hydrocarbon receptor regulates distinct dioxin-dependent and dioxin-independent gene batteries. Molecular Pharmacology. 69. 1. 2006. 140–153. 16214954. 10.1124/mol.105.018705. etal.
  8. Okey AB . An aryl hydrocarbon receptor odyssey to the shores of toxicology: the Deichmann Lecture, International Congress of Toxicology-XI . Toxicol. Sci. . 98 . 1 . 5–38 . July 2007 . 17569696 . 10.1093/toxsci/kfm096. free .
  9. Mandlekar S, Hong JL, Kong AN . Modulation of metabolic enzymes by dietary phytochemicals: a review of mechanisms underlying beneficial versus unfavorable effects . Curr. Drug Metab. . 7 . 6 . 661–75 . August 2006 . 16918318 . 10.2174/138920006778017795.
  10. Book: DeGroot . Danica . He . Guochun . Fraccalvieri . Domenico . Bonati . Laura . Pandini . Allesandro . Denison . Michael S. . The AH Receptor in Biology and Toxicology . 2011 . John Wiley & Sons, Ltd . 9781118140574 . 63–79 . en . AHR Ligands: Promiscuity in Binding and Diversity in Response. 10.1002/9781118140574.ch4 .
  11. Rothhammer . V . Quintana . FJ . The aryl hydrocarbon receptor: an environmental sensor integrating immune responses in health and disease. . Nature Reviews. Immunology . March 2019 . 19 . 3 . 184–197 . 10.1038/s41577-019-0125-8 . 30718831. 59603271 .
  12. Consultation on assessment of the health risk of dioxins: re-evaluation of the tolerable daily intake (TDI): Executive summary. Food Additives & Contaminants. 17. 2000. 223–240. 10.1080/713810655. 10912238. 4. 216644694.
  13. 10.1093/ije/dyl038 . 16543362 . Association between Agent Orange and birth defects: Systematic review and meta-analysis . International Journal of Epidemiology . 35 . 5 . 1220–1230 . 2006 . Ngo . Anh D . Taylor . Richard . Roberts . Christine L . Nguyen . Tuan V . dmy-all . free .
  14. 10.1080/026520300283360. Y.P. Dragan . D. Schrenk . Animal studies addressing the carcinogenicity of TCDD (or related compounds) with an emphasis on tumour promotion. Food Additives and Contaminants . 17. 4. 2000. 289–302. 10912243. 24500449 .
  15. M. Viluksela. Liver tumor-promoting activity of 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD) in TCDD-sensitive and TCDD resistant rat strains. Cancer Res. . 60. 2000. 24. 6911–620. 11156390. etal.
  16. Knerr S, Schrenk D . Carcinogenicity of 2,3,7,8-tetrachlorodibenzo-p-dioxin in experimental models . Mol Nutr Food Res . 50 . 10 . 897–907 . October 2006 . 16977593 . 10.1002/mnfr.200600006 .
  17. Cancer incidence in the population exposed to dioxin after the "Seveso accident": twenty years of follow-up. Angela Cecilia Pesatori . Dario Consonni . Maurizia Rubagotti . Paolo Grillo . Pier Alberto Bertazzi . Environmental Health . 2009. 8. 39. 10.1186/1476-069X-8-39. 19754930. 2754980. 1 . 2009EnvHe...8...39P . free .
  18. Book: International Agency for Research on Cancer . Polychlorinated dibenzo-para-dioxins and polychlorinated dibenzofurans . IARC . Lyon . 1997 . 978-92-832-1269-0 . 69 . Monographs on the Evaluation of Carcinogenic Risks to Humans.
  19. Book: IARC Working Group on the Evaluation of Carcinogenic Risk to Humans. 2,3,7,8-tetrachlorodibenzopara-dioxin, 2,3,4,7,8-pentachlorodibenzofuran, and 3,3',4,4',5-pentachlorobiphenyl. 2012. International Agency for Research on Cancer. 100F. 339–378. en.
  20. Kogevinas M, Becher H, Benn T, Bertazzi PA, Boffetta P, Bueno-de-Mesquita HB, Coggon D, Colin D, Flesch-Janys D, Fingerhut M, Green L, Kauppinen T, Littorin M, Lynge E, Mathews JD, Neuberger M, Pearce N, Saracci R . Cancer mortality in workers exposed to phenoxy herbicides, chlorophenols, and dioxins . Am J Epidemiol . 1997 . 145 . 12 . 1061–1075 . 10.1093/oxfordjournals.aje.a009069 . 9199536. free .
  21. Cole P, Trichopoulos D, Pastides H, Starr T, Mandel JS . Dioxin and cancer: a critical review . Regul. Toxicol. Pharmacol. . 38 . 3 . 378–388 . December 2003 . 14623487 . 10.1016/j.yrtph.2003.08.002.
  22. Walker NJ, Wyde ME, Fischer LJ, Nyska A, Bucher JR . Comparison of chronic toxicity and carcinogenicity of 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD) in 2-year bioassays in female Sprague-Dawley rats . Mol Nutr Food Res . 50 . 10 . 934–944 . October 2006 . 16977594 . 1934421 . 10.1002/mnfr.200600031 .
  23. Boffetta P, Mundt KA, Adami HO, Cole P, Mandel JS . TCDD and cancer: a critical review of epidemiologic studies . Crit. Rev. Toxicol. . 41 . 7 . 622–636 . August 2011 . 21718216 . 3154583 . 10.3109/10408444.2011.560141 .
  24. Buffler PA, Ginevan ME, Mandel JS, Watkins DK . The Air Force health study: an epidemiologic retrospective . Ann Epidemiol . 21 . 9 . 673–687 . September 2011 . 21441038 . 10.1016/j.annepidem.2011.02.001 .
  25. Warner . M . Mocarelli . P . Samuels . S . Needham . L . Brambilla . P . Eskenazi . B . Dioxin exposure and cancer risk in the Seveso Women's Health Study. . Environmental Health Perspectives . December 2011 . 119 . 12 . 1700–1705 . 10.1289/ehp.1103720 . 21810551. 3261987 .
  26. 10.1002/ijc.11635. J.T. Tuomisto . J. Pekkanen . H. Kiviranta . E. Tukiainen . T. Vartiainen . J. Tuomisto . Soft-tissue sarcoma and dioxin: a case-control study. Int. J. Cancer. 108. 6. 2004. 893–900. 14712494. free.
  27. Tuomisto, J.. Dioxin cancer risk –example of hormesis?. Dose-Response . 18648613. 3. 3. 2005. 332–341. 2475943. 10.2203/dose-response.003.03.004. etal.
  28. Malisch R, Kotz A . 2014 . Dioxins and PCBs in feed and food – review from European perspective. . The Science of the Total Environment . 491 . 2–10 . 10.1016/j.scitotenv.2014.03.022 . 24804623 . 2014ScTEn.491....2M .
  29. Web site: EPA's Reanalysis of Key Issues Related to Dioxin Toxicity and Response to NAS Comments (External Review Draft). US EPA National Center for Environmental Assessment,Cincinnati Oh. Rice. Glenn. cfpub.epa.gov. en. 2019-12-16.
  30. Web site: Health Effects. The Aspen Institute. 23 September 2019. August 2011.
  31. News: Toxic Substances Portal.
  32. 10.1146/annurev.pa.22.040182.002505. A. Poland . J.C. Knutson . 2,3,7,8-Tetrachlorodibenzo-p-dioxin and related halogenated aromatic hydrocarbons: examination of the mechanism of toxicity. Annu. Rev. Pharmacol. Toxicol.. 22 . 1982. 517–554. 6282188. 1.
  33. R. Pohjanvirta . J. Tuomisto . Short-term toxicity of 2,3,7,8-tetrachlorodibenzop-dioxin in laboratory animals: effects, mechanisms, and animal models. Pharmacol. Rev. . 46 . 1994. 4. 483–549. 7899475.
  34. 10.1080/026520300283351. L.S. Birnbaum . J. Tuomisto . Non-carcinogenic effects of TCDD in animals. Food Addit. Contam. . 17. 4. 2000. 275–288. 10912242. 45117354 .
  35. 10.1016/0041-008X(92)90103-Y. T.A. Mably . D.L. Bjerke . R.W. Moore . A. Gendron-Fitzpatrick . R.E. Peterson . In utero and lactational exposure of male rats to 2,3,7,8-tetrachlorodibenzo-pdioxin. 3. Effects on spermatogenesis and reproductive capability. Toxicol. Appl. Pharmacol.. 114. 1 . 1992. 118–126. 1585364.
  36. 10.1006/taap.1997.8223. L.E. Gray . J.S. Ostby . W.R. Kelce . A dose-response analysis of the reproductive effects of a single gestational dose of 2,3,7,8-tetrachlorodibenzo-p-dioxin in male Long Evans Hooded rat offspring. Toxicol. Appl. Pharmacol.. 146. 1 . 1997. 11–20. 9299592 .
  37. 10.1006/taap.2001.9216. H. Kattainen. In utero/lactational 2,3,7,8- tetrachlorodibenzo-p-dioxin exposure impairs molar tooth development in rats. Toxicol. Appl. Pharmacol.. 174. 3. 2001. 216–224. 11485382. etal.
  38. 10.1289/ehp.6920. S. Alaluusua. Developmental dental aberrations after the dioxin accident in Seveso. Environ. Health Perspect. . 112. 13. 2004. 1313–1318. 15345345. 1247522. etal.
  39. 10.1016/S0140-6736(05)77214-7. S. Alaluusua . P.L. Lukinmaa . J. Torppa . J. Tuomisto . T. Vartiainen . Developing teeth as biomarker of dioxin exposure. Lancet . 353 . 1999. 206. 9923879. 9148. 31562457 .
  40. 10.1016/0041-008X(78)90075-3. R.J. Kociba . Results of a two-year chronic toxicity and oncogenicity study of 2,3,7,8- tetrachlorodibenzo-p-dioxin in rats. Toxicol. Appl. Pharmacol. . 46 . 1978. 2. 279–303. 734660. etal.
  41. Schwarz M, Appel KE . Carcinogenic risks of dioxin: mechanistic considerations . Regul. Toxicol. Pharmacol. . 43 . 1 . 19–34 . October 2005 . 16054739 . 10.1016/j.yrtph.2005.05.008 .
  42. Book: H. C. . Pitot III . Y. P. . Dragan . Chemical carcinogenesis . C. D. . Klaassen . Casarett & Doull's Toxicology: the basic science of poisons . https://archive.org/details/Casarett_Doulls_Toxicology_The_Basic_Science_of_Pns_6th_Edition . McGraw-Hill . New York . 2001 . 978-0-07-134721-1 . 201–267 . 6th .
  43. Saracci . R. . Kogevinas . M. . Winkelmann . R. . Bertazzi . P. A. . Bueno De Mesquita . B. H. . Coggon . D. . Green . L. M. . Kauppinen . T. . l'Abbé . K. A. . 10.1016/0140-6736(91)91898-5 . 1681353 . Littorin . M. . Lynge . E. . Mathews . J. D. . Neuberger . M. . Osman . J. . Pearce . N. . Cancer mortality in workers exposed to chlorophenoxy herbicides and chlorophenols . The Lancet . 338 . 8774 . 1027–1032 . 1991 . 23115128 .
  44. Harnly . M. . Stephens . R. . McLaughlin . C. . Marcotte . J. . Petreas . M. . Goldman . L. . 10.1021/es00003a015 . Polychlorinated Dibenzo-p-dioxin and Dibenzofuran Contamination at Metal Recovery Facilities, Open Burn Sites, and a Railroad Car Incineration Facility . Environmental Science & Technology . 29 . 3 . 677–684 . 1995 . 22200276. 1995EnST...29..677H .
  45. [United States Department of Health and Human Services|DHHS]
  46. Jouko Tuomisto &al.: Synopsis on Dioxins and PCBs (accessed 2013-08-01), p.40; using data from EPA's National Center for Environmental Assessment
  47. 10.1080/15287399109531490. P. Mocarelli . Serum concentrations of 2,3,7,8- tetrachlorodibenzo-p-dioxin and test results from selected residents of Seveso, Italy. J. Toxicol. Environ. Health . 32. 4 . 1991. 357–366. 1826746. 1991JTEHA..32..357M . etal.
  48. 10.1016/S0140-6736(00)02290-X. P. Mocarelli. Paternal concentrations of dioxin and sex ratio of offspring. Lancet . 355. 9218. 2000. 1858–1863. 10866441. etal. 10281/16136. 6353869. free.
  49. 10.1289/ehp.01109865. A. Geusau . K. Abraham . K. Geissler . M.O. Sator . G. Stingl . E. Tschachler . Severe 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD) intoxication: clinical and laboratory effects. Environ. Health Perspect. . 109. 8. 2001. 865–869. 11564625. 1240417.
  50. O.. Sorg. M.. Zennegg. P.. Schmid. Fedosyuk. R.. R.. Valikhnovskyi. O.. Gaide. V.. Kniazevych. J.-H.. Saurat . 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD) poisoning in Victor Yushchenko: identification and measurement of TCDD metabolites . The Lancet . 374. 9696 . 2009 . 1179–1185 . 10.1016/S0140-6736(09)60912-0. 19660807. 24761553.
  51. 15384216 . 5 . 9 . Italian "Triangle of death" linked to waste crisis . Sep 2004 . Lancet Oncol . 525–527 . 10.1016/s1470-2045(04)01561-x. Senior . K . Mazza . A .
  52. Web site: Il triangolo della morte. rassegna.it. March 2007. 25 September 2014. 15 February 2009. https://web.archive.org/web/20090215053207/http://archivio.rassegna.it/2007/attualita/articoli/campania2.htm. dead.
  53. Web site: Discariche piene di rifiuti tossici quello è il triangolo della morte. 31 August 2004. la Repubblica.